Guardian Pharmacy Earnings: Margin Expansion And Raised Guidance Signal Operational Strength

robot
摘要生成中

Guardian Pharmacy Services (GRDN) reported strong Q4 2025 earnings, exceeding EPS estimates and showing significant margin expansion and robust EBITDA growth. The company raised its full-year 2026 adjusted EBITDA guidance, reflecting operational strength, successful acquisition integration, and improved vaccine profitability. Despite a muted market reaction due to maintained revenue guidance, management emphasized disciplined execution and scalable operations for continued growth.

此頁面可能包含第三方內容,僅供參考(非陳述或保證),不應被視為 Gate 認可其觀點表述,也不得被視為財務或專業建議。詳見聲明
  • 讚賞
  • 留言
  • 轉發
  • 分享
留言
請輸入留言內容
請輸入留言內容
暫無留言